These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Neuroleptic malignant syndrome: a rare long lasting case report]. Lemos J; Mós M; Monteiro A; Henriques P Acta Med Port; 2010; 23(6):1155-9. PubMed ID: 21627894 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration. Norris B; Angeles V; Eisenstein R; Seale JP Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106 [TBL] [Abstract][Full Text] [Related]
10. In the Balance: A Case of Neuroleptic Malignant Syndrome When Donepezil Is Added to Maintenance Haloperidol Decanoate. Mican LM; Schulenberg S J Pharm Technol; 2014 Dec; 30(6):235-239. PubMed ID: 34860886 [No Abstract] [Full Text] [Related]
11. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case. Brogna P; Colasuonno R; Di Michele F; Paterniti AM; Talamo A; Ribolsi M; Jannini TB; Siracusano A; Niolu C Riv Psichiatr; 2020; 55(4):236-239. PubMed ID: 32724236 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Yacoub A; Francis A Neuropsychiatr Dis Treat; 2006 Jun; 2(2):235-40. PubMed ID: 19412469 [TBL] [Abstract][Full Text] [Related]
13. Four cases of neuroleptic malignant syndrome. McLean DR; Hafez MS; Duarte-Afara RR; Obeid ME Ann Saudi Med; 1992 Jan; 12(1):24-9. PubMed ID: 17589122 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of neuroleptic malignant syndrome. Guerrero RM; Shifrar KA Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662 [TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine]. Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891 [TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome due to olanzapine. Hall KL; Taylor WH; Ware MR Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and treatment of neuroleptic malignant syndrome. Ebadi M; Pfeiffer RF; Murrin LC Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219 [TBL] [Abstract][Full Text] [Related]
19. Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent. Yıldırım V; Direk MÇ; Güneş S; Okuyaz Ç; Toros F Clin Psychopharmacol Neurosci; 2017 Feb; 15(1):76-78. PubMed ID: 28138117 [TBL] [Abstract][Full Text] [Related]
20. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. Liu PY; Wu PC; Chen CY; Chen YC Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]